Clinical Trial Update: Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer

View source ↗

Summary

A Mayo Clinic-sponsored clinical trial is evaluating methylated DNA markers to detect endometrial, ovarian, and cervical cancers, with recruitment currently ong…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atypical Endometrial Hyperplasia
• Cervical Cancer
• Cervical Dysplasia
• Endometrial Cancer
• Ovarian Cancer

Snippet

Sponsor: Mayo Clinic | Conditions: Endometrial Cancer, Cervical Cancer | Status: RECRUITING